Author

J. Licht

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:proteomics· 1

Frequent Co-Authors

J. Li· 2 shared A. Chen· 1 shared A. J. Lamberto· 1 shared A. M. Barsotti· 1 shared A. Pon· 1 shared A. Riva· 1 shared A. W. Stamford· 1 shared B. Fang· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

J. Li

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Recruitment of FBXO22 for Targeted Degradation of NSD2

D. Y. Nie, J. R. Tabor, J. Li, M. Kutera, J. St-Germain, R. P. Hanley, E. Z. WOLF, E. Paulakonis, T. M. G. Kenney, S. Duan, S. Shrestha, D. D. Owens, A. Pon, M. Szewczyk, A. J. Lamberto, , C. Arrowsmith

This paper describes a targeted protein degradation strategy using UNC8732 to recruit FBXO22 for NSD2 degradation, leading to growth suppression and reversal of drug resistance in leukemia cells.

bioRxiv · Nov 1, 2023Biochemistry

HDAC8-mediated inhibition of EP300 drives a neural crest-like transcriptional state that increases melanoma brain metastasis

M. F. Emmons, R. L. Bennett, A. Riva, C. Zhang, R. Macaulay, D. Dupere-Richer, B. Fang, E. Seto, J. Koomen, J. Li, A. Chen, P. Forsyth, J. Licht, K. S. M. Smalley

bioRxiv · Oct 12, 2022 · PreprintCancer Biology